ALB and renal cell carcinoma: The HALP(hemoglobin, albumin, lymphocyte, and platelet) score, which is calculated using hemoglobin, albumin, lymphocyte, and platelet levels, is one such index that has been studied in several cancers, including renal cell carcinoma, lung cancer, and gastric cancer (4–6).